Log in to save to my catalogue

43/#512 Assessing robustness of an artificial intelligence derived histological biomarker across dif...

43/#512 Assessing robustness of an artificial intelligence derived histological biomarker across dif...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2747762900

43/#512 Assessing robustness of an artificial intelligence derived histological biomarker across different sites of disease and in serial sections in tubo-ovarian high-grade serous carcinoma

About this item

Full title

43/#512 Assessing robustness of an artificial intelligence derived histological biomarker across different sites of disease and in serial sections in tubo-ovarian high-grade serous carcinoma

Publisher

Kidlington: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A45-A46

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

ObjectivesHistological biomarkers may produce different predictions for a single patient when using whole slide images of biopsies from different sites and even serial sections of the same tissue. Previous work had developed a signature of AI-derived morphologic features correlated with response to platinum-based chemotherapy in tubo-ovarian high-g...

Alternative Titles

Full title

43/#512 Assessing robustness of an artificial intelligence derived histological biomarker across different sites of disease and in serial sections in tubo-ovarian high-grade serous carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2747762900

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2747762900

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2022-igcs.87

How to access this item